→click here to view the full programme from the forum.
Rajat Agrawal
CEO & President, Retina Global Affiliated Faculty, USC Eye Institute, Los Angeles, USA
Mourad Amrane
MD, Senior Director Global Biomedical Science, Santen
Laurent Attias
Senior Vice President, Corporate Development Strategy, Alcon
Gerd Auffarth
MD, PhD, FEBO, Professor and Chairman, Dept. of Ophthalmology, University of Heidelberg. Director, David J. Apple International Laboratory for Ocular Pathology. International Vision Correction Research Centre, Heidelberg, Germany
Michael Ball
CEO, Alcon, USA
Duncan Bishop
Programme Director, Medical Technology Division, Cambridge Consultants
Leonard Borrmann
Head of External Innovation, Johnson & Johnson Vision
Mary Cantu
Director, Market Access International Markets, Glaukos
Alex Chigarev
Head of Sales, Reper-NN
Minas Coroneo
Professor AO. BSC(MED), MB BS, MSC SYD, MD, MS UNSW, FRACS, FRANZCO. Professor and Chairman, Department of Ophthalmology, University of New South Wales, Sydney, Australia
Alan Crandall
John A. Moran Presidential Professor, Val A. and Edith D. Green, Presidential Endowed Chair, Senior Vice Chair, Director of Glaucoma and Cataract, Co-Director, Moran Outreach Division, USA
David Cristina
Senior Investment Consultant – Life Sciences & MedTech, Portugal Ventures
Arthur Cummings
FRCS, MD, Medical Director Wellington Eye Clinic & Beacon Hospital Head of Ophthalmology, Dublin, Ireland
Eugene de-Juan Jr.
ForSight Labs and University of California, San Francisco, USA
Robert Dempsey
MBA, Group Vice President, Head of Global Ophthalmics Franchise, Shire
Burkhard Dick
Professor of Ophthalmology, Chairman and Head of the University Eye Clinic Bochum, Germany
Thomas Dyrberg
MD, DMSc, Managing Partner, Novo Ventures
> F
Tom Frinzi
Worldwide President, Johnson & Johnson Vision
Julian Garcia-Feijoo
Professor Dr. JGF; Prof and Chairman Ophthalmology Department, Hospital Clinico San Carlos, Universidad Complutense Madrid, Spain
Rafiq Hasan
VP and Global Head, Ophthalmology, Bayer AG
Mark Humayun
University of Southern California
Seph Jensen
CEO, TearLab
Carsten Laue
CEO, Infinite Vision Optics
William Link
PhD, Managing Director, Versant Ventures. Founder, CEO, Chiron Vision, USA
Boris Malyugin
Prof. MD, PhD, Deputy Director General (R&D, Edu)., S. Fyodorov Institute, Russia
James Mazzo
Global President Ophthalmic Devices, Carl Zeiss Meditec AG, USA
Ludwin Monz
President and CEO,Carl Zeiss Meditec AG. Carl Zeiss AG Executive Board member
Leighton Morris
Global HEOR Director – Glaucoma, Alcon
Dirk Mühlhoff
Vice President Refractive Laser, Carl Zeiss Meditec AG
Ram Palanki
Senior Vice President, Commercial-Americas, Santen
Jai Parekh
MD, MBA, FAAO, Vice-President, Eye Care & Dermatology. Global Head, Eye Care & Dermatology Medical Affairs, Office of the CMO, Allergan
Jane Rady
Vice President, Business Development, Surgical, Johnson & Johnson Vision
MK Raheja
Head of R&D, Ophthalmic Implants at Johnson & Johnson Vision
Rajesh Rajpal
Chief Medical Officer, Avedro
Christian Rathjen
PhD, VP Technology & Strategy, Ziemer Ophthalmic Systems AG
Ramgopal Rao
CEO and Founder, LensGen
Karlheinz Rein
Vice President, Product Management & Marketing, Surgical Ophthalmology, Carl Zeiss Meditec AG
Calvin Roberts
MD, Senior Vice President, Chief Medical Officer, Bausch + Lomb
Baldo Scassellati Sforzolini
MD, PhD, MBA, Senior Vice President, Clinical Development, Allergan
Sunil Shah
Midland Eye and Visiting Professor, Aston University
Naveed Shams
MD, PhD, Head of Global R&D, Chief Scientific Officer, Senior Corporate Officer, Santen
Naveed Siddiqi
Partner, Edmond de Rothschild Investment Partners
Rufino Silva
MD, PhD, FEBO, Head of Medical Retina Unit. Department of Ophthalmology. Centro Hospitalar e Universitario de Coimbra (CHUC), Portugal. Invited Professor. Faculty of Medicine. University of Coimbra. Institute for Biomedical Imaging and Life Sciences (FMUC-IBILI). Portugal. Principal Inestigator. Association for Innovation and Biomedical Research on Light and Image (AIBILI). Coimbra. Portugal
Chelvin Sng
Consultant and Assistant Professor, National University Hospital, Singapore
Einar Stefánsson
MD, PhD, Professor and Chairman of Ophthalmology, University of Iceland, National University Hospital. Editor-in-Chief, Acta Ophthalmologica. President, EU EYE
Julian Stevens
Consultant Ophthalmologist, Moorfields Eye Hospital, London
Klaus Stöckemann
Dr., Managing Partner & Co-Founder, Peppermint Venture Partners
Karl Stonecipher
MD, Clinical Associate Professor, Ophthalmology, University of North Carolina. Medical Director, Physicians Protocol. Medical Director, Laser Defined Vision. Medical Director, Restoration Med Spa.Medical Director, TLC Greensboro, USA
Jonathan Talamo
MD, Chief Medical Officer, Johnson & Johnson Vision
Fotis Tefos
Associate Director, Devices Access & Reimbursement, Allergan
Brian Walsh
CEO, IanTech
Mark Wuttke
Global Program Head, Ophthalmology, Novartis Pharmaceuticals, Spain
AcuFocus Yari Mitchell – Vice President
Camras Vision Ray Krauss – CEO
Elasmogen Dr. Caroline Barelle – CEO
EyeYon Medical Dr. Brian Levy – Executive Director
Implandata Max Ostermeier – CEO
Infinite Vision Optics Dr. Carsten Laue – President
Innfocus Inc Russ Trenary – CEO and President
Kali Care Sina Fateh – CEO
LensGen Ramgopal Rao – CEO and Founder
Medicem Eugen Chicevic – CEO and Co-Founder
Mupharma Dr. Harry Unger – Chairman & Founder
Mynosys Cellular Systems John N. Hendrick – President and CEO
OptoLight Vision Isaac Lipshitz – CEO and Medical Director
Presbia Todd Cooper – CEO and President
Re-Vana Therapeutics Michael O’Rourke – CEO
Refocus Mike Judy – President and CEO
Reper-NN Alex Chigarev – Head of Marketing
Rheon Medical Nikos Stergiopulos – CEO
Sensimed AG David Bailey – CEO
SRD Vision Ted Newill – CEO and President
TearLab Seph Jensen – CEO
Vivior AG Mario Stark – CEO
Voptica Pablo Artal – CEO and Founder
Z-Lens Paul Maurius Beer – CEO and Founder